Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A PHASE 1A/B OPEN-LABEL MASTER STUDY OF PF-07799544 AS A SINGLE-AGENT AND IN COMBINATION WITH OTHER TARGETED AGENTS IN PARTICIPANTS WITH BRAF-MUTANT MELANOMA AND OTHER SOLID TUMORS
The purpose of this clinical trial is to learn the safety and effects of the study medicine (PF-07799544) alone or in combination as a potential cancer treatme…
MelanomaGliomaThyroid Cancer+10 more
Estimated
~$10 – $7,500
PfizerNCT05538130
Phase 2
A Phase 2 Master Protocol to Assess the Efficacy and Safety of FORE8394, an Inhibitor of BRAF Class 1 and Class 2 Alterations, in Participants With Cancer Harboring BRAF Alterations
The objective of this Master Protocol is to evaluate the efficacy and safety of plixorafenib in participants with BRAF altered (BRAF V600E or BRAF fusions) loc…
Cancer Harboring BRAF AlterationsHGGLGG+1 more
Estimated
~$10 – $8,750
Fore BiotherapeuticsNCT05503797